1McMurray J J, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J, 2012,33 (14) : 1787-1847.
2Fox K,Ford I,Steg PG,et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial[J]. Lancet,2008,372 (9641) :817-821.
3Swedberg K, Komaida M, B6hm M, et al. Ivahradine and outcomes in chronic heart failure (SHIFT): a randomized placebo controlled study[J]. Lancet, 2010,376(9744):875- 885.
4B6hm M,Swedberg K,Koraajda M,et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomized placebo- controlled trialFlT. Lancet, 2010,378 (9744), 886-894.
6Sossalla S, Mazur M, Kallmeyer B, et al. Anti-arrbythmic properties of ranolazine and improved diastolic function in isolated human atrial myocardium[J]. J Am Coil Cardiol, 2010,55(21) :2330-2342.
7Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure[J]. J Mol Cell Cardiol, 2002,34 (8) : 951-969.
8Undrovinas AI, Belardinelli I., Undrovinas NA, et al. Ranolazine improves abnormal repolarization and contraction in left ventrieular myocytes of dogs with heart failure by inhibiting late sodium current[J]. J Cardiovasc Electrophysiol, 2006,17(Suppl 1) :S169-S177.
9Figueredo VM, Pressman GS, Romero-Corral A, et al. Improvement in left ventricular systolic and diastolic performance during ranolazine treatment in. patients with stable angina[J]. J Cardiovasc Pharmacol Ther, 2011,16 (2) ; 168-172.
10Maier LS, Layug B, Karwatowska-Prokopczuk E, et al. RAnolazine for the treatment of diastolic heart failure inpatients with preservedejection fraction: the RALI-DHF prooLoLconcept study[J]. JACC Heart Fail, 2013,1 (2) : 115- 122.
二级参考文献36
1McMurray JJ, Adamopoulos S, Anker SD,et al. ESC Guidelinesfor the diagnosis and treatment of acute and chronic heartfailure 2012[J], Eur Heart J,2012,33(14) : 1787-1847.
2Zarrinkoub R,Wettermark B,Wandell P,et al. Theepidemiology of heart failure, based on data for 2. 1 millioninhabitants in Sweden[J], Eur J Heart Fail,2013,15(9) : 995-1002.
3Piller LB’Baraniuk S,Simpson LM,et al. Long-term follow-upof participants with heart failure in the antihypertensive andlipid-lowering treatment to prevent heart attack trial(ALLHAT)[J]. Circulation,2011,124(17) :1811-1818.
4Roger VL. Epidemiology of heart failure[J]. Circ Res, 2013,113(6): 646-659.
5Yancy CW,Jessup M, Bozkurt B,et al. 2013 ACCF/AHAguideline for the management of heart failure: executivesummary[J]. J Am Coll Cardiol,2013,62(16) : 1495-1539.
6Taranikanti V, Banerjee Y. Antihypertensive treatment ofpatients with cardiovascular disease but without hypertension[J]. JAMA,20X1,305(21) ;2170.
7Rosendorff C,Black HR, Cannon CP, et al. Treatment ofhypertension in the prevention and management of ischemicheart disease: a scientific statement from the American HeartAssociation Council for High Blood Pressure Research and theCouncils on Clinical Cardiology and Epidemiology andPrevention[J]. Circulation,2007,115(21) :2761-2788.
8Anand IS, Rector TS. Kuskowski M, et al. Effect of baseline.and changes in systolic blood pressure over time on theeffectiveness of valsartan in the Valsartan Heart Failure Trial[J]. Circ Heart Fail,2008,1(1) :34-42.
9Stevenson LW. Management of acute decompensated heartfailure [ M]//Mann DL. Heart failure: a companion toBraunwalds heart disease. 2nd ed. St. Louis; Saunders, 2011 :634-649.
10Metra M, Bristow MR. Antagonism of the sympathetic nervoussystem in heart failure [ M]//Mann DL. Heart failure: acompanion to Braunwald's heart disease. 2nd ed. St. Louis;Saunders,2011:674-693.
4Dib JE,Matin SA,Luckert A.Prehospital use of continuous positive airway pressure for acute severe congestive heart failure[J].J Emerg Med,2012,42(5):553-558.
5Dursunoglu D,Dursunoglu N.Non-invasive mechanical ventilation therapy in patients with heart failure[J].Anadolu Kardiyol Derg,2012,12(3):261-268.
